bodrum escort
antalya escort bayan
beylikduzu escort sirinevler escort beylikduzu escort
anal porno zdarma hot sexy black girls xxx old man and girl

Critical Questions

MenAfriNet’s strategic approach is guided by a number of questions:

  • What is the long-term effectiveness of meningococcal conjugate A vaccine (MACV/PsA–TT, manufactured by the Serum Institute of India, Ltd. as MenAfriVac™) against meningococcal A meningitis?
  • Is there a change in the circulating organisms causing meningitis, i.e., an emergence of meningococcal epidemics due to other serogroups or additional disease due to pneumococcus?
  • What is the indirect protection from MACV and how long will herd immunity protect unvaccinated cohorts?
  • What are the implications for future vaccine policy and decisions about the need for a multivalent vaccine?

High-quality laboratory and case-based surveillance data, geographically and time-based epidemiologic and molecular data analysis, and special studies, using the MenAfriNet network as a platform, will be essential to answering these critical questions.